scholarly article | Q13442814 |
P50 | author | Simon Wessely | Q15439895 |
P2093 | author name string | C Taïeb | |
K Le Lay | |||
L Annemans | |||
E Spaepen | |||
K Caekelbergh | |||
J P Caubère | |||
P2860 | cites work | Current and future forecasts of service use and expenditures of Medicaid-eligible schizophrenia patients in the state of Georgia | Q40414295 |
P433 | issue | 3 | |
P921 | main subject | fibromyalgia | Q540571 |
P304 | page(s) | 895-902 | |
P577 | publication date | 2008-03-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Health economic consequences related to the diagnosis of fibromyalgia syndrome | |
P478 | volume | 58 |
Q36905958 | 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary |
Q47410773 | A Survey of Physicians' Knowledge and Adherence to the Diagnostic Criteria for Fibromyalgia |
Q36633380 | A randomized controlled trial of qigong for fibromyalgia |
Q84970272 | Comparison of Medication Adherence and Healthcare Costs between Duloxetine and Pregabalin Initiators among Patients with Fibromyalgia |
Q39824439 | Cost-Saving Early Diagnosis of Functional Pain in Nonmalignant Pain: A Noninferiority Study of Diagnostic Accuracy. |
Q48305481 | Diagnosis and management of fibromyalgia: how and why. |
Q34418217 | Duloxetine for the management of fibromyalgia syndrome. |
Q64229640 | Effectiveness and cost-effectiveness of the modified Pilates method versus aerobic exercise in the treatment of patients with fibromyalgia: protocol for a randomized controlled trial |
Q47164101 | Fibromyalgia Syndrome: A Metabolic Approach Grounded in Biochemistry for the Remission of Symptoms. |
Q34434050 | Fibromyalgia and the therapeutic relationship: where uncertainty meets attitude |
Q34325229 | Fibromyalgia syndrome. General principles and coordination of clinical care and patient education |
Q38601633 | Fibromyalgia: A Critical and Comprehensive Review |
Q48408018 | Fibromyalgia: current diagnosis and management |
Q38185990 | Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden |
Q34511064 | Fibromyalgia: management strategies for primary care providers |
Q58297413 | Fibromyalgia—worth a diagnosis? |
Q90207715 | Frequency of mental disorders among chronic pain patients with or without fibromyalgia in Japan |
Q37844532 | Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study |
Q91906280 | Impact of water therapy on pain management in patients with fibromyalgia: current perspectives |
Q34887973 | Improving the recognition and diagnosis of fibromyalgia |
Q55516153 | Interdisciplinary assessment-oriented treatment of fibromyalgia: a case report. |
Q53149184 | Measuring functioning in people with fibromyalgia (FM) based on the international classification of functioning, disability and health (ICF)--a psychometric analysis. |
Q90317145 | Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders |
Q47652632 | Normalizing fibromyalgia as a chronic illness |
Q37896383 | Pharmacotherapy of fibromyalgia |
Q57704293 | Prevalence and frequency of self-perceived systemic features in people with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type |
Q37252987 | Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia |
Q37676178 | Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST) |
Q36834489 | Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial |
Q37575438 | Societal and patient burden of fibromyalgia syndrome |
Q26801572 | The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects |
Q50993412 | [Fibromyalgia]. |
Search more.